Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects

NCT04873570 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Healthy Individuals
Bioequivalence Study

Interventions

DRUG: Moxifloxacin 400mg

Sponsor

University of Karachi

Collaborators

[object Object]
[object Object]